Latest news

Insights

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Executive Summary Drug development in 2026 is undergoing a structural transformation driven by AI-enabled discovery, precision medicine, advanced biologics, and...
Uncategorized

Top 10 Emerging Trends in Life Sciences for 2026

Emerging Trends:Executive Summary The life sciences industry in 2026 is entering a phase of accelerated transformation, driven by the convergence...
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a fundamental transformation, driven by next-generation modalities, platform-based innovation, and precision...
Commercial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Eli Lilly continues its rapid pace of dealmaking, announcing the acquisition of Ajax Therapeutics to gain access to a...
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Clinical

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

The domvanalimab, an anti-TIGIT antibody from Gilead Sciences and...
Clinical

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

A late-stage clinical trial evaluating a three-drug combination for renal cell carcinoma (RCC) did not achieve its primary objectives,...
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across its Massachusetts operations following the U.S. Food and Drug Administration’s...
Clinical

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Results of a mid-stage trial reported that twice as many patients with advanced pancreatic cancer treated with an experimental...
Clinical

Pfizer Stops Work on Next-Gen Drug For Cancer Patients

Pfizer has discontinued development of a PD-L1–targeting therapy that...
Regulatory

FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case

The Federal Trade Commission has reached a settlement with...
Clinical

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Aligos Therapeutics has reached an agreement with hepatology-focused biopharma company Amoytop, obtaining $25 million in upfront cash in exchange...
Commercial

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in a transaction valued at up to $1.1 billion, combining cash...
Commercial

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Eli Lilly has agreed to acquire CrossBridge Bio, a Houston-based biotechnology company focused on cancer treatments, as part of...
Regulatory

FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case

The Federal Trade Commission has reached a settlement with...
Editorial Team -
Commercial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Eli Lilly continues its rapid pace of dealmaking, announcing...
Editorial Team -
Commercial

AstraZeneca Joins Hands With New Chinese Biotech to Work on Hypercholesterolemia

AstraZeneca is partnering up with a self-identified "young" Chinese...
Commercial

Teva Secures $100M Funding to Expedite Schizophrenia Drug Development

Teva has tapped into royalty funding to speed up...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

FTC, U.S. Anesthesia Partners Reach Settlement in Texas Price Collusion Case

The Federal Trade Commission has reached a settlement with...
Editorial Team -
Uncategorized

Top 10 Emerging Trends in Life Sciences for 2026

Emerging Trends:Executive Summary The life sciences industry in 2026 is...
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a...
Commercial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Eli Lilly continues its rapid pace of dealmaking, announcing...
Clinical

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

Oruka Therapeutics reported interim results from a phase 2a...

Research & Development

Market Access

Manufacturing

Novartis Plans 550 Layoffs in Switzerland While Expanding U.S. Manufacturing Footprint

 550 Layoffs ;Novartis has outlined several updates to its...
Manufacturing

FDA Issues Fresh Criticism of Novo Nordisk Indiana Manufacturing Plant

FDA Cites Manufacturing Deficiencies at Indiana Plant Novo Nordisk’s manufacturing...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Executive Summary Drug development in 2026 is undergoing a structural...
Editorial Team -
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...
Editorial Team -
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a...
Editorial Team -